Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2009

01.10.2009 | Retinal Disorders

Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema

verfasst von: Jan Kalvoda, Jaroslava Dušková, Aleš Kuběna, Ctibor Povýšil, Bohdana Kalvodová

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Histopathologic and morphometric analysis of the internal limiting membrane (ILM) in diabetic eyes was performed. The thickness of the ILM was correlated with the level of glykosylated hemoglobin (HbA1C) and other clinical factors.

Methods

The prospective study involved 56 eyes of 52 diabetic patients with a mean age of 63 ± 7.6 years. Vitrectomy with trypan blue-assisted ILM peeling was performed in the standard way. The mean follow-up period was 8.7 months (range 3–19 months). The ILM was fixed immediately after peeling in 2.5% glutaraldehyde and submitted for electron microscopic evaluation. The ILM was photographed at standard magnification (×5,000) with the scale of 1 µm in the shot.

Results

Morphometric analysis demonstrated a significant thickening of the ILM in all eyes, with a mean thickness of the ILM of 3.61 ± 1.22 µm. It was found that a higher thickness of the ILM is related to elevated HbA1C in both types of diabetes mellitus (DM) (p = 0.040). We also found significant dependence of ILM thickness in relation to duration of DM by comparison of men and women (p = 0.026), and a significant correlation between ILM thickness and the age of diabetic patients related to their gender (p = 0.029).

Conclusions

We confirmed increased thickness of the surgically peeled ILM and statistically significant correlations to elevated HbA1C in both types of DM, and to further clinical characteristics of case series. Morphometric and histopathologic analyses of the ILM contribute to more objective evaluation of the ultrastructure of the vitreomacular interface.
Literatur
1.
Zurück zum Zitat Joussen AM, Naumann GO, Coupland SE, Tamm ER, Kirchhof B, Bornfeld N (2008) Retina and Vitreous. In: Naumann GO, Holbach L, Kruse FE et al (eds) Applied pathology for ophthalmic microsurgeons. Springer, Berlin Heidelberg New York, pp 306–307 Joussen AM, Naumann GO, Coupland SE, Tamm ER, Kirchhof B, Bornfeld N (2008) Retina and Vitreous. In: Naumann GO, Holbach L, Kruse FE et al (eds) Applied pathology for ophthalmic microsurgeons. Springer, Berlin Heidelberg New York, pp 306–307
4.
Zurück zum Zitat Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy. Retina 20:54–555 Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy. Retina 20:54–555
5.
Zurück zum Zitat Sakamoto T, Miyazaki M, Hisatomi T et al (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423–429, doi:10.1007/s00417-002-0454-2 PubMedCrossRef Sakamoto T, Miyazaki M, Hisatomi T et al (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423–429, doi:10.​1007/​s00417-002-0454-2 PubMedCrossRef
10.
Zurück zum Zitat Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y (2003) Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Ophthalmic Res 35:192–198, doi:10.1159/000071170 PubMedCrossRef Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y (2003) Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Ophthalmic Res 35:192–198, doi:10.​1159/​000071170 PubMedCrossRef
11.
12.
Zurück zum Zitat Avci R, Kaderli B, Avci B, Simsek S, Baykara M, Kahveci Z, Gelisken O, Yucel AA (2004) Pars plana vitrectomy and removal of the internal limiting in the treatment of chronic macular oedema. Graefes Arch Clin Exp Ophthalmol 242:845–852, doi:10.1007/s00417-004-0939-2 PubMedCrossRef Avci R, Kaderli B, Avci B, Simsek S, Baykara M, Kahveci Z, Gelisken O, Yucel AA (2004) Pars plana vitrectomy and removal of the internal limiting in the treatment of chronic macular oedema. Graefes Arch Clin Exp Ophthalmol 242:845–852, doi:10.​1007/​s00417-004-0939-2 PubMedCrossRef
15.
Zurück zum Zitat Lewis H, Abrams GW, Blumenkranz MS, Camppo R (1999) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloids traction. Ophthalmology 99:753–759 Lewis H, Abrams GW, Blumenkranz MS, Camppo R (1999) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloids traction. Ophthalmology 99:753–759
19.
Zurück zum Zitat Stefaniotou M, Aspiotis M, Kalogeropoulos C, Christodoulou A, Osykla M, Ioachhim E, Alamanos I, Psilas K (2004) Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 14:137–143PubMed Stefaniotou M, Aspiotis M, Kalogeropoulos C, Christodoulou A, Osykla M, Ioachhim E, Alamanos I, Psilas K (2004) Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 14:137–143PubMed
20.
Zurück zum Zitat Kalvodová B, Záhlava J (2002) Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography. Čes a slov Oftal 58:224–232 Kalvodová B, Záhlava J (2002) Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography. Čes a slov Oftal 58:224–232
22.
Zurück zum Zitat Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258–260PubMed Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258–260PubMed
23.
Zurück zum Zitat Foss RI (1972) Vitreoretinal juncture: topographical variations. Invest Ophthalmol 11:801–808 Foss RI (1972) Vitreoretinal juncture: topographical variations. Invest Ophthalmol 11:801–808
24.
Zurück zum Zitat Bron AJ, Tripathi RC, Tripathi BJ (1997) Wolff's anatomy of the eye. (The inner limiting membrane). Chapman & Hall, London, p 488 Bron AJ, Tripathi RC, Tripathi BJ (1997) Wolff's anatomy of the eye. (The inner limiting membrane). Chapman & Hall, London, p 488
25.
26.
Zurück zum Zitat Sebag J (1991) Age-related differences in the human vitreoretinal interface. Arch Ophthalmol 109:966–971PubMed Sebag J (1991) Age-related differences in the human vitreoretinal interface. Arch Ophthalmol 109:966–971PubMed
27.
Zurück zum Zitat Ducournau D, Ducournau Y (2008) A Closer Look at the ILM. Removal of the ILM induces a cellular response that allows the retina to fight against edema. A Supplement to Retinal Physician, July/August:4–15 Ducournau D, Ducournau Y (2008) A Closer Look at the ILM. Removal of the ILM induces a cellular response that allows the retina to fight against edema. A Supplement to Retinal Physician, July/August:4–15
28.
Zurück zum Zitat The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes. N Engl J Med 329:977–986, doi:10.1056/NEJM199309303291401 CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes. N Engl J Med 329:977–986, doi:10.​1056/​NEJM199309303291​401 CrossRef
29.
Zurück zum Zitat Prospective Diabetes Study Group UK (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. BMJ 317:703–713 Prospective Diabetes Study Group UK (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. BMJ 317:703–713
Metadaten
Titel
Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema
verfasst von
Jan Kalvoda
Jaroslava Dušková
Aleš Kuběna
Ctibor Povýšil
Bohdana Kalvodová
Publikationsdatum
01.10.2009
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 10/2009
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-009-1100-z

Weitere Artikel der Ausgabe 10/2009

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2009 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.